Loading
Latest filing published 11 Feb 2016 for Ocata Therapeutics, Inc.. Read the official filing
No signal scores available.
Brian Levy is a declared insider of Ocata Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 31 December 2015 and 10 February 2016, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 February 2016 came the latest disclosure, a transaction in Ocata Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations